Share Price:

APNASPENAspen Pharmacare Hldgs17485-14 (-0.08%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Partnering with the South African Department of Health to Enhance Public Healthcare

One of Aspen’s key business imperatives is the creation of stakeholder value. The communities Aspen operates within remain amongst the Group’s most important stakeholders, with healthcare being one of the key aspects to ensuring sustainable communities.

While South Africa is currently burdened with one of the world’s most disproportionate disease profiles, it also has enthusiastic and spirited healthcare workers and a large human capital base that can be tapped into. In line with Aspen’s commitment to develop this human capital and to resource the South African healthcare sector, Aspen has spearheaded the formation of The Public Health Enhancement Fund (PHEF) in South Africa, resulting in a private/public partnership and social compact between the South African Department of Health and the South African private sector.  This partnership has had an considerable positive impact on the public healthcare sector in South Africa – below is a link to short video providing a brief insight into this partnership and the benefits derived from it.

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.